Company · CIK 0000200406 · SIC 2834 — Pharmaceutical Preparations · NYSE
JOHNSON & JOHNSON · JNJ
Insider activity reported against this company. All insider holders · Files at: PRVB, INSP, ACHN, NERV, PTGX, NVRO, NGNE. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 SForm 4 → | Sep 4, 9:08 am EDT | Timothy SchmidEVP, WW Chair, MedTech | 33,597 | $274.74 | $9,230,440 | 25,447 | −56.9% | |
| Sep 2, 2026 MForm 4 → | Sep 4, 9:08 am EDT | Timothy SchmidEVP, WW Chair, MedTech | 33,597 | $144.99 | $4,871,389 | 47,974 | — | |
| Aug 17, 2026 SForm 4 → | Aug 18, 6:31 pm EDT | Jennifer L TaubertEVP, WWC. Innovative Medicine | 15,000 | $263.36 | $3,950,400 | 194,451 | −7.16% | |
| Aug 17, 2026 MForm 4 → | Aug 18, 6:31 pm EDT | Jennifer L TaubertEVP, WWC. Innovative Medicine | 15,000 | $115.67 | $1,735,050 | 209,451 | — | |
| Aug 13, 2026 SForm 4 → | Aug 14, 4:35 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 123,291 | $261.17 | $32,199,927 | 275,967 | −30.9% | |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:35 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 123,291 | $115.67 | $14,261,070 | 399,258 | — | |
| Aug 6, 2026 SForm 4 → | Aug 7, 5:44 pm EDT | Elizabeth ForminardEVP, Chief Legal Officer | 15,918 | $257.00 | $4,090,960 | 16,994 | −48.4% | |
| Aug 6, 2026 MForm 4 → | Aug 7, 5:44 pm EDT | Elizabeth ForminardEVP, Chief Legal Officer | 9,344 | $131.94 | $1,232,847 | 32,912 | — | |
| Aug 5, 2026 SForm 4 → | Aug 7, 5:50 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 48,480 | $258.15 | $12,515,010 | 275,967 | −14.9% | |
| Jul 20, 2026 SForm 4 → | Jul 21, 5:27 pm EDT | Vanessa BroadhurstEVP, Global Corp Affairs | 23,054 | $251.27 | $5,792,686 | 23,003 | −50.1% | |
| Jul 20, 2026 MForm 4 → | Jul 21, 5:27 pm EDT | Vanessa BroadhurstEVP, Global Corp Affairs | 23,054 | $130.77 | $3,014,701 | 46,057 | — | |
| Jun 11, 2026 SForm 4 → | Jun 12, 5:23 pm EDT | Kathryn E WengelEVP, Chief TO and Risk Officer | 10,000 | $241.15 | $2,411,500 | 114,288 | −8.05% | |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:23 pm EDT | Kathryn E WengelEVP, Chief TO and Risk Officer | 10,000 | $115.67 | $1,156,700 | 124,288 | — | |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:15 pm EST | Ronald A KapustaController, CAO | 7,462 | $131.97 | $220,780 | 17,757 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:15 pm EST | Joseph J WolkExec VP, CFO | 7,617 | $131.97 | $224,078 | 13,920 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:15 pm EST | Peter FasoloExec VP, Chief HR Officer | 29,441 | $131.95 | $1,282,579 | 88,328 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:15 pm EST | Kathryn E WengelEVP, Chief GSC Officer | 20,126 | $131.96 | $847,197 | 41,601 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:15 pm EST | Jennifer L TaubertEVP, WW Chair, Pharmaceuticals | 29,677 | $131.96 | $1,293,358 | 73,751 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:15 pm EST | Paulus StoffelsVice Chair, Exec Committee | 69,357 | $131.95 | $2,665,975 | 231,516 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:14 pm EST | Michael E SneedEVP, Global Corp Aff & COO | 20,157 | $131.96 | $702,558 | 49,383 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:14 pm EST | Jorge S. MesquitaExec VP, WW Chair, Consumer | 41,124 | $131.95 | $1,924,657 | 27,344 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:14 pm EST | Ashley McEvoyEVP, WW Chair, Medical Devices | 20,779 | $131.96 | $712,849 | 19,468 | — | plan? |
| Feb 8, 2019 AFMForm 4 → | Feb 12, 9:14 pm EST | Joaquin DuatoVice Chair, Exec Committee | 49,616 | $131.95 | $1,878,070 | 114,705 | — | plan? |
| Dec 14, 2018 PForm 4 → | Dec 17, 8:37 am EST | Anne M MulcahyDirector | 748 | $133.76 | $100,050 | 6,537 | +12.9% | plan? |
| Dec 14, 2018 PForm 4 → | Dec 17, 8:37 am EST | William D PerezDirector | 1,000 | $133.91 | $133,910 | 9,122 | +12.3% | plan? |
| Dec 14, 2018 PForm 4 → | Dec 17, 8:37 am EST | Charles PrinceDirector | 2,000 | $134.37 | $268,731 | 28,520 | +7.54% | plan? |
| Dec 13, 2018 SForm 4 → | Dec 14, 4:33 pm EST | Ronald A KapustaController, CAO | 3,643 | $147.31 | $536,638 | 13,641 | −21.1% | plan? |
| Dec 11, 2018 AFGMForm 4 → | Feb 12, 2019, 9:14 pm EST | Alex GorskyChairman, CEO, Director | 178,409 | $131.95 | $6,476,582 | 389,456 | — | plan? late |
| Dec 3, 2018 SForm 4 → | Dec 6, 5:27 pm EST | Peter FasoloExec VP, Chief HR Officer | 166,695 | $146.41 | $24,405,241 | 78,327 | −68.0% | plan? |
| Dec 3, 2018 MForm 4 → | Dec 6, 5:27 pm EST | Peter FasoloExec VP, Chief HR Officer | 166,695 | $94.77 | $15,798,156 | 119,890 | — | plan? |
| Nov 23, 2018 SForm 4 → | Nov 27, 6:56 pm EST | Michael E SneedEVP, Global Corp Aff & COO | 30,943 | $142.46 | $4,407,985 | 39,874 | −43.7% | plan? |
| Nov 23, 2018 MForm 4 → | Nov 27, 6:56 pm EST | Michael E SneedEVP, Global Corp Aff & COO | 30,943 | $58.33 | $1,804,905 | 70,817 | — | plan? |
| Nov 16, 2018 SForm 4 → | Nov 16, 7:44 pm EST | Alex GorskyChairman, CEO, Director | 264,465 | $145.96 | $38,600,968 | 336,559 | −44.0% | plan? |
| Nov 16, 2018 MForm 4 → | Nov 16, 7:44 pm EST | Alex GorskyChairman, CEO, Director | 264,465 | $62.39 | $16,500,026 | 601,024 | — | plan? |
| Nov 8, 2018 SForm 4 → | Nov 9, 5:22 pm EST | Ronald A KapustaController, CAO | 8,441 | $145.15 | $1,225,200 | 17,284 | −32.8% | plan? |
| Nov 7, 2018 SForm 4 → | Nov 9, 5:20 pm EST | Joaquin DuatoVice Chair, Exec Committee | 40,000 | $144.36 | $5,774,480 | 93,555 | −30.0% | plan? |
| Nov 7, 2018 MForm 4 → | Nov 9, 5:20 pm EST | Joaquin DuatoVice Chair, Exec Committee | 40,000 | $62.94 | $2,517,526 | 133,555 | — | plan? |
| Sep 7, 2018 SForm 4 → | Sep 11, 3:53 pm EDT | Ronald A KapustaController, CAO | 7,899 | $137.18 | $1,083,607 | 25,725 | −23.5% | plan? |
| Aug 27, 2018 IForm 4 → | Sep 17, 5:51 pm EDT | Ashley McEvoyEVP, WW Chair, Medical Devices | 142 | $134.92 | $19,159 | 2,215 | — | plan? late |
| Aug 27, 2018 SForm 4 → | Aug 28, 4:03 pm EDT | Michael E SneedEVP, Global Corp Aff & COO | 29,000 | $134.80 | $3,909,084 | 30,124 | −49.0% | plan? |
| Aug 27, 2018 MForm 4 → | Aug 28, 4:03 pm EDT | Michael E SneedEVP, Global Corp Aff & COO | 29,000 | $58.33 | $1,691,570 | 59,124 | — | plan? |
| Mar 9, 2018 AFGMForm 4 → | Feb 12, 2019, 9:15 pm EST | Michael H UllmannExec VP, General Counsel | 31,808 | $131.95 | $1,356,999 | 133,460 | — | plan? late |
| Feb 15, 2018 SForm 4 → | Feb 20, 7:46 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 155,342 | $129.86 | $20,172,401 | 202,564 | −43.4% | plan? |
| Feb 15, 2018 MForm 4 → | Feb 20, 7:46 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 155,342 | $90.44 | $14,049,130 | 357,906 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:15 pm EST | Ronald A KapustaController, CAO | 3,147 | $129.51 | $90,268 | 33,624 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:14 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 47,847 | $129.51 | $1,876,082 | 93,555 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:14 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 64,621 | $129.51 | $2,533,734 | 202,564 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:14 pm EST | Dominic J CarusoExec VP, Finance; CFO | 51,698 | $129.51 | $2,027,091 | 171,659 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:14 pm EST | Peter FasoloExec VP, Chief HR Officer | 29,292 | $129.51 | $1,226,589 | 78,327 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:13 pm EST | Michael H UllmannExec VP, General Counsel | 29,935 | $129.51 | $1,255,599 | 123,750 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:13 pm EST | Sandra E PetersonExec VP, Group WW Chairman | 59,732 | $129.51 | $2,696,269 | 83,349 | — | plan? |
| Feb 12, 2018 AFMForm 4 → | Feb 14, 6:13 pm EST | Alex GorskyChairman, CEO | 161,724 | $129.51 | $6,341,069 | 336,559 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 6:55 pm EST | Ronald A KapustaController, CAO | 3,497 | $128.18 | $101,903 | 31,871 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 6:55 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 17,836 | $128.18 | $587,577 | 177,071 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 6:54 pm EST | Sandra E PetersonExec VP, Group WW Chairman | 16,395 | $128.18 | $634,491 | 65,255 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 6:54 pm EST | Peter FasoloExec VP, Chief HR Officer | 7,845 | $128.18 | $258,283 | 67,977 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 6:54 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 13,480 | $128.18 | $470,164 | 74,680 | — | plan? |
| Feb 9, 2018 FMForm 4 → | Feb 13, 6:54 pm EST | Dominic J CarusoExec VP, Finance; CFO | 14,039 | $128.18 | $440,683 | 151,265 | — | plan? |
| Feb 2, 2018 FMForm 4 → | Feb 6, 4:21 pm EST | Jorge S. MesquitaExec VP, WW Chair, Consumer | 49,984 | $138.88 | $2,402,068 | 15,392 | — | plan? |
| Dec 4, 2017 FGMForm 4 → | Feb 13, 2018, 6:54 pm EST | Alex GorskyChairman, CEO | 53,549 | $128.18 | $1,695,950 | 272,759 | — | plan? late |
| Oct 31, 2017 FMForm 4 → | Nov 2, 5:01 pm EDT | Paulus StoffelsExec VP, Chief Scientific Off | 110,234 | $139.54 | $4,847,899 | 168,400 | — | plan? |
| Oct 24, 2017 GForm 4 → | Dec 14, 5:50 pm EST | William D PerezDirector | 2,400 | — | — | 9,100 | — | plan? late |
| Jul 24, 2017 SForm 4 → | Jul 26, 11:49 am EDT | Paulus StoffelsExec VP, Chief Scientific Off | 102,692 | $133.14 | $13,672,629 | 127,650 | −44.6% | plan? |
| Jul 24, 2017 MForm 4 → | Jul 26, 11:49 am EDT | Paulus StoffelsExec VP, Chief Scientific Off | 102,692 | $72.54 | $7,449,278 | 230,342 | — | plan? |
| Jul 20, 2017 SForm 4 → | Jul 24, 11:06 am EDT | Dominic J CarusoExec VP, Finance; CFO | 82,591 | $136.72 | $11,291,478 | 144,102 | −36.4% | plan? |
| Jul 20, 2017 MForm 4 → | Jul 24, 11:06 am EDT | Dominic J CarusoExec VP, Finance; CFO | 82,591 | $61.75 | $5,099,994 | 226,693 | — | plan? |
| Mar 3, 2017 SForm 4 → | Mar 7, 4:21 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 50,000 | $123.62 | $6,181,140 | 68,536 | −42.2% | plan? |
| Mar 3, 2017 MForm 4 → | Mar 7, 4:21 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 50,000 | $59.76 | $2,987,780 | 118,536 | — | plan? |
| Feb 28, 2017 SForm 4 → | Mar 2, 5:50 pm EST | Ronald A KapustaController, CAO | 14,543 | $122.26 | $1,777,954 | 29,964 | −32.7% | plan? |
| Feb 28, 2017 MForm 4 → | Mar 2, 5:50 pm EST | Ronald A KapustaController, CAO | 14,543 | $72.54 | $1,054,949 | 44,507 | — | plan? |
| Feb 28, 2017 SForm 4 → | Mar 2, 5:16 pm EST | Gary J PrudenExec VP, WW Chair, Med Devices | 16,299 | $122.21 | $1,991,943 | 43,630 | −27.2% | plan? |
| Feb 27, 2017 FGMForm 4 → | Feb 13, 2018, 6:55 pm EST | Michael H UllmannExec VP, General Counsel | 8,801 | $128.18 | $263,025 | 113,205 | — | plan? late |
| Feb 15, 2017 SForm 4 → | Feb 16, 6:53 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 22,000 | $117.29 | $2,580,274 | 127,650 | −14.7% | plan? |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Joaquin DuatoExec VP, WW Chair, Pharma | 47,370 | $115.67 | $1,870,962 | 68,536 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Gary J PrudenExec VP, WW Chair, Med Devices | 31,402 | $115.67 | $1,118,876 | 59,929 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Ronald A KapustaController, CAO | 3,950 | $115.67 | $109,308 | 29,964 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Michael H UllmannExec VP, General Counsel | 31,016 | $115.67 | $1,225,061 | 110,100 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Paulus StoffelsExec VP, Chief Scientific Off | 54,026 | $115.67 | $1,969,513 | 149,650 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Sandra E PetersonExec VP, Group WW Chairman | 60,421 | $115.67 | $2,511,774 | 58,760 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Alex GorskyChairman, CEO | 172,208 | $115.67 | $6,277,874 | 259,978 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 16, 6:01 am EST | Peter FasoloExec VP, Chief HR Officer | 32,783 | $115.67 | $1,267,859 | 64,162 | — | plan? late |
| Feb 13, 2017 AFMForm 4 → | Feb 15, 10:00 pm EST | Dominic J CarusoExec VP, Finance; CFO | 55,049 | $115.67 | $2,006,875 | 144,102 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Ronald A KapustaController, CAO | 4,263 | $115.13 | $119,965 | 27,904 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Michael H UllmannExec VP, General Counsel | 8,869 | $115.13 | $348,729 | 100,266 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 14,179 | $115.13 | $414,468 | 129,678 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Gary J PrudenExec VP, WW Chair, Med Devices | 8,183 | $115.13 | $226,806 | 47,873 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Sandra E PetersonExec VP, Group WW Chairman | 16,009 | $115.13 | $568,972 | 41,769 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Alex GorskyChairman, CEO | 47,971 | $115.13 | $1,640,718 | 196,318 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Peter FasoloExec VP, Chief HR Officer | 8,584 | $115.13 | $269,980 | 53,301 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 12,282 | $115.13 | $387,182 | 53,516 | — | plan? |
| Feb 10, 2017 FMForm 4 → | Feb 14, 5:49 pm EST | Dominic J CarusoExec VP, Finance; CFO | 14,478 | $115.13 | $425,866 | 123,753 | — | plan? |
| Feb 1, 2017 SForm 4 → | Feb 3, 12:05 pm EST | Michael H UllmannExec VP, General Counsel | 21,735 | $112.88 | $2,453,442 | 97,455 | −18.2% | plan? |
| Feb 1, 2017 MForm 4 → | Feb 3, 12:05 pm EST | Michael H UllmannExec VP, General Counsel | 27,735 | $65.62 | $1,819,971 | 119,190 | — | plan? |
| Oct 21, 2016 PForm 4 → | Oct 25, 1:52 pm EDT | Charles PrinceDirector | 875 | $114.11 | $99,846 | 26,520 | +3.41% | plan? |
| Jul 26, 2016 SForm 4 → | Jul 28, 4:34 pm EDT | Dominic J CarusoExec VP, Finance; CFO | 41,146 | $125.01 | $5,143,810 | 116,673 | −26.1% | plan? |
| Jul 26, 2016 MForm 4 → | Jul 28, 4:34 pm EDT | Dominic J CarusoExec VP, Finance; CFO | 41,146 | $65.62 | $2,700,001 | 157,819 | — | plan? |
| Jul 22, 2016 SForm 4 → | Jul 25, 3:18 pm EDT | Ronald A KapustaController, CAO | 2,935 | $125.01 | $366,896 | 25,725 | −10.2% | plan? |
| Jul 21, 2016 MForm 4 → | Jul 25, 3:18 pm EDT | Ronald A KapustaController, CAO | 2,935 | $58.33 | $171,199 | 28,660 | — | plan? |
| Jun 7, 2016 SForm 4 → | Jun 9, 4:12 pm EDT | Gary J PrudenExec VP, WW Chair, Med Devices | 9,735 | $116.03 | $1,129,552 | 43,630 | −18.2% | plan? |
| Jun 7, 2016 SForm 4 → | Jun 9, 4:11 pm EDT | Ronald A KapustaController, CAO | 3,000 | $115.79 | $347,381 | 25,725 | −10.4% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 AForm 4 → | Sep 10, 8:51 pm EDT | Daniel E PintoDirector | 113 | $276.31 | $31,250 | 2,445 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 8:50 pm EDT | Eugene A. WoodsDirector | 136 | $276.31 | $37,500 | 6,579 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 8:50 pm EDT | Marillyn A HewsonDirector | 181 | $276.31 | $50,000 | 16,049 | — | |
| Sep 2, 2026 MForm 4 → | Sep 4, 9:08 am EDT | Timothy SchmidEVP, WW Chair, MedTech | 33,597 | — | — | 0 | — | |
| Aug 17, 2026 MForm 4 → | Aug 18, 6:31 pm EDT | Jennifer L TaubertEVP, WWC. Innovative Medicine | 15,000 | — | — | 28,712 | — | |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:35 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 123,291 | — | — | 0 | — | |
| Aug 6, 2026 MForm 4 → | Aug 7, 5:44 pm EDT | Elizabeth ForminardEVP, Chief Legal Officer | 9,344 | — | — | 0 | — | |
| Jul 20, 2026 MForm 4 → | Jul 21, 5:27 pm EDT | Vanessa BroadhurstEVP, Global Corp Affairs | 23,054 | — | — | 0 | — | |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:23 pm EDT | Kathryn E WengelEVP, Chief TO and Risk Officer | 10,000 | — | — | 32,965 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:56 pm EDT | Eugene A. WoodsDirector | 161 | $232.79 | $37,500 | 6,412 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:43 pm EDT | Daniel E PintoDirector | 134 | $232.79 | $31,250 | 2,321 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:35 pm EDT | Marillyn A HewsonDirector | 215 | $232.79 | $50,000 | 15,792 | — | |
| Mar 12, 2019 AForm 4 → | Mar 13, 12:46 pm EDT | A. Eugene WashingtonDirector | 341 | — | — | 19,344 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | Ian DavisDirector | 1,402 | — | — | 13,007 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | Jennifer A DoudnaDirector | 1,402 | — | — | 1,402 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | Mark B. McClellanDirector | 1,402 | — | — | 9,884 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | Anne M MulcahyDirector | 1,402 | — | — | 13,007 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | Ronald A WilliamsDirector | 1,402 | — | — | 20,361 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | A. Eugene WashingtonDirector | 1,402 | — | — | 19,003 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | William D PerezDirector | 1,402 | — | — | 24,254 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | Charles PrinceDirector | 1,402 | — | — | 19,577 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:55 pm EST | D Scott DavisDirector | 1,402 | — | — | 7,922 | — | |
| Feb 12, 2019 AForm 4 → | Feb 13, 2:14 pm EST | Mary C BeckerleDirector | 1,402 | — | — | 6,222 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Ronald A KapustaController, CAO | 13,617 | — | — | 1,414 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Joseph J WolkExec VP, CFO | 75,077 | — | — | 3,248 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Peter FasoloExec VP, Chief HR Officer | 61,307 | — | — | 2,036 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Kathryn E WengelEVP, Chief GSC Officer | 53,253 | — | — | 1,896 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Michael H UllmannExec VP, General Counsel | 70,189 | — | — | 2,407 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Jennifer L TaubertEVP, WW Chair, Pharmaceuticals | 88,971 | — | — | 3,297 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:15 pm EST | Paulus StoffelsVice Chair, Exec Committee | 164,180 | — | — | 5,606 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:14 pm EST | Michael E SneedEVP, Global Corp Aff & COO | 46,160 | — | — | 1,517 | — | |
| Feb 8, 2019 MForm 4 → | Feb 12, 9:14 pm EST | Jorge S. MesquitaExec VP, WW Chair, Consumer | 23,755 | — | — | 0 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:14 pm EST | Ashley McEvoyEVP, WW Chair, Medical Devices | 75,997 | — | — | 2,885 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:14 pm EST | Alex GorskyChairman, CEO, Director | 342,119 | — | — | 11,129 | — | |
| Feb 8, 2019 AMForm 4 → | Feb 12, 9:14 pm EST | Joaquin DuatoVice Chair, Exec Committee | 147,965 | — | — | 5,424 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:53 pm EST | Ronald A WilliamsDirector | 350 | — | — | 18,959 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:48 pm EST | A. Eugene WashingtonDirector | 307 | — | — | 17,601 | — | |
| Dec 3, 2018 MForm 4 → | Dec 6, 5:27 pm EST | Peter FasoloExec VP, Chief HR Officer | 166,695 | — | — | 0 | — | |
| Nov 23, 2018 MForm 4 → | Nov 27, 6:56 pm EST | Michael E SneedEVP, Global Corp Aff & COO | 30,943 | — | — | 0 | — | |
| Nov 16, 2018 MForm 4 → | Nov 16, 7:44 pm EST | Alex GorskyChairman, CEO, Director | 264,465 | — | — | 0 | — | |
| Nov 7, 2018 MForm 4 → | Nov 9, 5:20 pm EST | Joaquin DuatoVice Chair, Exec Committee | 40,000 | — | — | 0 | — | |
| Sep 11, 2018 AForm 4 → | Sep 13, 4:43 pm EDT | Ronald A WilliamsDirector | 364 | — | — | 18,608 | — | |
| Sep 11, 2018 AForm 4 → | Sep 13, 4:43 pm EDT | A. Eugene WashingtonDirector | 320 | — | — | 17,294 | — | |
| Aug 27, 2018 MForm 4 → | Aug 28, 4:03 pm EDT | Michael E SneedEVP, Global Corp Aff & COO | 29,000 | — | — | 30,943 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 6:59 pm EDT | Ronald A WilliamsDirector | 404 | — | — | 18,244 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 6:59 pm EDT | A. Eugene WashingtonDirector | 354 | — | — | 16,974 | — | |
| Mar 13, 2018 AForm 4 → | Mar 15, 2:00 pm EDT | Ronald A WilliamsDirector | 363 | — | — | 17,841 | — | |
| Mar 13, 2018 AForm 4 → | Mar 15, 2:00 pm EDT | A. Eugene WashingtonDirector | 318 | — | — | 16,620 | — | |
| Feb 15, 2018 MForm 4 → | Feb 20, 7:46 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 155,342 | — | — | 0 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:17 pm EST | Ronald A WilliamsDirector | 1,428 | — | — | 17,477 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:16 pm EST | A. Eugene WashingtonDirector | 1,428 | — | — | 16,301 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:13 pm EST | Charles PrinceDirector | 1,428 | — | — | 17,703 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:12 pm EST | William D PerezDirector | 1,428 | — | — | 22,260 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:11 pm EST | Anne M MulcahyDirector | 1,428 | — | — | 11,304 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:11 pm EST | Ian DavisDirector | 1,428 | — | — | 11,304 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:11 pm EST | D Scott DavisDirector | 1,428 | — | — | 6,351 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:11 pm EST | Mark B. McClellanDirector | 1,428 | — | — | 8,262 | — | |
| Feb 13, 2018 AForm 4 → | Feb 15, 6:11 pm EST | Mary C BeckerleDirector | 1,428 | — | — | 4,695 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:15 pm EST | Ronald A KapustaController, CAO | 13,569 | — | — | 2,048 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:14 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 135,120 | — | — | 5,283 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:14 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 150,556 | — | — | 5,610 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:14 pm EST | Dominic J CarusoExec VP, Finance; CFO | 116,764 | — | — | 4,312 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:14 pm EST | Peter FasoloExec VP, Chief HR Officer | 57,689 | — | — | 2,060 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:13 pm EST | Jorge S. MesquitaExec VP, WW Chair, Consumer | 52,053 | — | — | 2,487 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:13 pm EST | Michael H UllmannExec VP, General Counsel | 63,254 | — | — | 2,311 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:13 pm EST | Sandra E PetersonExec VP, Group WW Chairman | 127,285 | — | — | 4,714 | — | |
| Feb 12, 2018 AMForm 4 → | Feb 14, 6:13 pm EST | Alex GorskyChairman, CEO | 334,449 | — | — | 12,017 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:55 pm EST | Ronald A KapustaController, CAO | 2,702 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:55 pm EST | Michael H UllmannExec VP, General Counsel | 5,953 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:55 pm EST | Paulus StoffelsExec VP, Chief Scientific Off | 13,252 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:54 pm EST | Sandra E PetersonExec VP, Group WW Chairman | 11,445 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:54 pm EST | Alex GorskyChairman, CEO | 33,165 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:54 pm EST | Peter FasoloExec VP, Chief HR Officer | 5,830 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:54 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 9,812 | — | — | 0 | — | |
| Feb 9, 2018 MForm 4 → | Feb 13, 6:54 pm EST | Dominic J CarusoExec VP, Finance; CFO | 10,601 | — | — | 0 | — | |
| Feb 2, 2018 MForm 4 → | Feb 6, 4:21 pm EST | Jorge S. MesquitaExec VP, WW Chair, Consumer | 32,688 | — | — | 0 | — | |
| Dec 12, 2017 AForm 4 → | Dec 14, 5:50 pm EST | Ronald A WilliamsDirector | 325 | — | — | 16,049 | — | |
| Dec 12, 2017 AForm 4 → | Dec 14, 5:50 pm EST | A. Eugene WashingtonDirector | 283 | — | — | 14,873 | — | |
| Dec 12, 2017 AForm 4 → | Dec 14, 5:50 pm EST | William D PerezDirector | 354 | — | — | 20,832 | — | |
| Oct 31, 2017 MForm 4 → | Nov 2, 5:01 pm EDT | Paulus StoffelsExec VP, Chief Scientific Off | 75,492 | — | — | 0 | — | |
| Sep 12, 2017 AForm 4 → | Sep 14, 6:24 pm EDT | Ronald A WilliamsDirector | 344 | — | — | 15,724 | — | |
| Sep 12, 2017 AForm 4 → | Sep 14, 6:24 pm EDT | A. Eugene WashingtonDirector | 299 | — | — | 14,590 | — | |
| Sep 12, 2017 AForm 4 → | Sep 14, 6:24 pm EDT | William D PerezDirector | 374 | — | — | 20,478 | — | |
| Jul 24, 2017 MForm 4 → | Jul 26, 11:49 am EDT | Paulus StoffelsExec VP, Chief Scientific Off | 102,692 | — | — | 0 | — | |
| Jul 20, 2017 MForm 4 → | Jul 24, 11:06 am EDT | Dominic J CarusoExec VP, Finance; CFO | 82,591 | — | — | 0 | — | |
| Jun 13, 2017 AForm 4 → | Jun 15, 4:34 pm EDT | Ronald A WilliamsDirector | 343 | — | — | 15,380 | — | |
| Jun 13, 2017 AForm 4 → | Jun 15, 4:34 pm EDT | A. Eugene WashingtonDirector | 298 | — | — | 14,292 | — | |
| Jun 13, 2017 AForm 4 → | Jun 15, 4:34 pm EDT | William D PerezDirector | 373 | — | — | 20,104 | — | |
| Mar 14, 2017 AForm 4 → | Mar 16, 5:54 pm EDT | Ronald A WilliamsDirector | 350 | — | — | 15,037 | — | |
| Mar 14, 2017 AForm 4 → | Mar 16, 5:54 pm EDT | A. Eugene WashingtonDirector | 304 | — | — | 13,993 | — | |
| Mar 14, 2017 AForm 4 → | Mar 16, 5:54 pm EDT | William D PerezDirector | 380 | — | — | 19,731 | — | |
| Mar 3, 2017 MForm 4 → | Mar 7, 4:21 pm EST | Joaquin DuatoExec VP, WW Chair, Pharma | 50,000 | — | — | 0 | — | |
| Feb 28, 2017 MForm 4 → | Mar 2, 5:50 pm EST | Ronald A KapustaController, CAO | 14,543 | — | — | 14,544 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 10:00 pm EST | Ronald A WilliamsDirector | 1,512 | — | — | 14,687 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 9:59 pm EST | A. Eugene WashingtonDirector | 1,512 | — | — | 13,689 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 9:59 pm EST | Charles PrinceDirector | 1,512 | — | — | 15,874 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 9:59 pm EST | William D PerezDirector | 1,512 | — | — | 19,352 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 9:59 pm EST | Anne M MulcahyDirector | 1,512 | — | — | 9,633 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 9:59 pm EST | Mark B. McClellanDirector | 1,512 | — | — | 6,666 | — | |
| Feb 14, 2017 AForm 4 → | Feb 15, 9:59 pm EST | Ian DavisDirector | 1,512 | — | — | 9,633 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2018 CForm 4 → | Jul 20, 10:11 am EDT | Provention Bio, Inc.PRVB | 2,400,000 | — | — | 2,400,000 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 4:50 pm EDT | Inspire Medical Systems, Inc.INSP | 235,251 | — | — | 235,251 | — | plan? |
| Nov 20, 2017 SForm 4 → | Nov 22, 11:44 am EST | ACHILLION PHARMACEUTICALS INCACHN | 18,367,346 | $2.75 | $50,510,202 | 0 | −100% | plan? |
| Aug 29, 2017 JForm 4 → | Sep 14, 4:33 pm EDT | Minerva Neurosciences, Inc.NERV | 3,892,256 | $0.0001 | $389 | 0 | — | plan? late |
| Aug 16, 2016 PForm 4 → | Aug 18, 5:11 pm EDT | Protagonist Therapeutics, IncPTGX | 583,333 | $12.00 | $6,999,996 | 2,449,183 | +31.3% | plan? |
| Aug 16, 2016 CForm 4 → | Aug 18, 5:11 pm EDT | Protagonist Therapeutics, IncPTGX | 1,865,850 | — | — | 1,865,850 | — | plan? |
| Aug 10, 2015 SForm 4 → | Aug 12, 12:24 pm EDT | AQUINOX PHARMACEUTICALS, INCAQXP | 1,514,821 | $22.41 | $33,944,876 | 100,000 | −93.8% | plan? |
| Jun 8, 2015 SForm 5 → | Feb 12, 2016, 11:48 am EST | NEVRO CORPNVRO | 1,010,265 | $48.00 | $48,492,720 | 2,066,740 | −32.8% | plan? |
| Jun 8, 2015 SForm 4 → | Jun 8, 4:40 pm EDT | NEVRO CORPNVRO | 1,010,265 | $47.94 | $48,432,104 | 2,066,740 | −32.8% | plan? |
| Mar 18, 2015 PForm 5 → | Feb 12, 2016, 11:54 am EST | Minerva Neurosciences, Inc.NERV | 607,903 | $4.93 | $2,996,962 | 3,892,256 | +18.5% | plan? |
| Mar 13, 2015 PForm 4 → | Mar 17, 6:43 pm EDT | Minerva Neurosciences, Inc.NERV | 607,903 | $4.81 | $2,924,013 | 4,500,159 | +15.6% | plan? |
| Mar 12, 2014 PForm 4/A → | Feb 3, 2015, 12:05 pm EST | AQUINOX PHARMACEUTICALS, INCAQXP | 272,727 | $11.00 | $2,999,997 | 1,664,821 | +19.6% | plan? |
| Mar 12, 2014 CForm 4/A → | Feb 3, 2015, 12:05 pm EST | AQUINOX PHARMACEUTICALS, INCAQXP | 1,392,094 | — | — | 1,392,094 | — | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2018 CForm 4 → | Jul 20, 10:11 am EDT | Provention Bio, Inc.PRVB | 2,400,000 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 4:50 pm EDT | Inspire Medical Systems, Inc.INSP | 1,393,669 | — | — | 0 | — | |
| Aug 16, 2016 CForm 4 → | Aug 18, 5:11 pm EDT | Protagonist Therapeutics, IncPTGX | 27,054,830 | — | — | 0 | — | |
| Mar 13, 2015 PForm 4 → | Mar 17, 6:43 pm EDT | Minerva Neurosciences, Inc.NERV | 607,903 | $0.125 | $75,988 | 607,903 | — | |
| Mar 12, 2014 CForm 4/A → | Feb 3, 2015, 12:05 pm EST | AQUINOX PHARMACEUTICALS, INCAQXP | 1,392,094 | — | — | 0 | — |